Latest Capillary hemangioma Stories
PARSIPPANY, N.J., Feb.
Pierre Fabre Dermatologie has retained Inclinix, Inc., to assist in the enrollment of patients for the HEMANGIOL study, a Phase II/III clinical trial of a potential treatment for reducing infantile hemangioma (IH), also known as strawberry birthmark.
NEW ORLEANS, Feb. 4, 2011 /PRNewswire/ -- Vascular birthmarks, which occur in nearly 10 percent of all infants at birth or within the first few weeks of life, can cause concern for parents particularly if they are large or in a cosmetically important area.
In an ongoing effort to find better and safer treatment for complicated infantile hemangiomas, researchers at The Medical College of Wisconsin and Children's Hospital of Wisconsin, report outcomes on two treatment options.
Hemangiomas -- strawberry-like birthmarks that commonly develop in early infancy -- are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing.
New research finds that a genetic defect test performed during early pregnancy appears to increase the chances that a baby will be born with an infantile hemangioma, or birthmark.
A U.S.-led team of medical scientists says it's discovered the cause of the rapid growth seen in infantile hemangioma, a common childhood tumor.
The September/October issue of Archives of Facial Plastic Surgery, one of the JAMA/Archives journals, contains several articles on the current state of knowledge and experience with vascular birthmarks, which are caused by blood vessels that do not form correctly.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.